National Academy of Sciences | 150 Year Anniversary

Questions? Call 800-624-6242

| Items in cart [0]

The National Academies Press

PAPERBACK
price:$28.00
add to cart

Rights & Permissions

topleft topright

Immunization Safety Review: Measles-Mumps-Rubella Vaccine and Autism (2001)
Institute of Medicine (IOM)

Citation Manager

. "Appendix D: Research Needs and Opportunities Related to the Measles-Mumps-Rubella Vaccine and Autism." Immunization Safety Review: Measles-Mumps-Rubella Vaccine and Autism. Washington, DC: The National Academies Press, 2001.

Please select a format:

BibTeX EndNote RefMan


Page
86
bottomleft bottomright

The following HTML text is provided to enhance online readability. Many aspects of typography translate only awkwardly to HTML. Please use the page image as the authoritative form to ensure accuracy.


Page 86

tional light on the mechanisms that produce autism. Cross-national studies were also mentioned because autism rates seem to be similar across countries that have differing immunization levels and practices. To gain a better understanding of the basic neuroanatomy and neurochemistry of the autistic brain, systematic and more frequent postmortem examinations should be encouraged. In addition, new technologies, such as noninvasive imaging, have the potential to provide better information on brain function and structure.

Research studies might also explore whether identifiable features of genetics, immune function, or other factors predispose some children to an adverse vaccine reaction and whether the brain can be protected in such children. For example, animal models point to changes in brain vulnerability as neonates age, so the effect of changes in the timing of immunization might be studied. It was noted that although the idea of finding markers for genetic susceptibility is appealing, such tools might be hard to use because of the cost of screening all children.

Page
86